Crossmark

TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1–TSC2 complex

Crossref DOI link: https://doi.org/10.1038/onc.2017.349

Published Online: 2017-10-02

Published Print: 2018-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Guo, P

Ma, X

Zhao, W

Huai, W

Li, T

Qiu, Y

Zhang, Y

Han, L
License Information

Text and Data Mining valid from 2017-10-02
More Information

Article History

Received: 14 December 2016

Revised: 16 August 2017

Accepted: 21 August 2017

First Online: 2 October 2017

Competing interests

: The authors declare no conflict of interest.